TXN and hepatocellular carcinoma: However, in our study, the ROC curve comparing all the HCC patients showed that thioredoxin was superior to AFP in diagnosing HCC with an AUROC of 0.95 (95% CI: 0.92–0.97) and a sensitivity of 84.3%, and a specificity of 91.8% (AFP: 0.88).